High-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.
Human Nav1.8/b3 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6011. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™ , IonWorks Quattro®
Human a3/β4 Nicotinic Acetylcholine Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6021. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: QPatch HT™
Human GABAA (α5β2γ2) Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6119. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human GABAA (a5β2γ2) Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6119. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human Cav2.2/b3/a2d calcium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6159. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™ , FLIPR®
Human Cav2.1/b4/a2d calcium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6196. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™
Human GABAA (α3/β2/γ2) Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7022. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human a7 Nicotinic Acetylcholine Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6201. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch HT™ , FLIPR®
Human Cav2.1/β4/α2δ calcium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6196. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™
Human Nav1.8/β3 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4011. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human α3/β4 Nicotinic Receptor-expressing, division-arrested cells (CHO-K1). Cat#: CT4021. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Human GABAA (α5/β2/γ2) ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4119. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Human GABAA (a5/b2/g2) ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4119. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Human Cav2.2/b3/a2d1 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4159. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human GABAA (α2β2γ2) Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6118. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human α7+RIC-3 Nicotinic Receptor-expressing, division-arrested cells (CHO-K1). Cat#: CT4201. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Human GABAA (a3/b2/g2) Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7022. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human b2 Adrenergic Receptor-expressing GPCR (G protein-coupled receptor) stable, replicating cell line (CHO-K1). Cat#: A600. Cryopreserved cells, 6 million cells per vial
Human b2 Adrenergic Receptor-expressing GPCR (G protein-coupled receptor) division-arrested cells (CHO-K1). Cat#: A400. Cryopreserved irradiated cells, 6 million cells per vial
Human a3/β4 Nicotinic Receptor membrane preparation derived from stable, replicating cell line. (Cat#: CT3021)
Human NCX1 Na+/Ca2+ Exhanger-expressing, stable replicating cell line (HEK293). Cat#: CT6206. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human NCX1 Na+/Ca2+ Exhanger-expressing, transiently transfected cells (HEK293). Cat#: CT7206. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: Manual Patch Clamp, FLIPR®
Human Kv11.1 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6001. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™
Human Kv11.1 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6002. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch HT™ , IonWorks Quattro®
Human Nav1.7 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6003. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , IonWorks Quattro® , FLIPR®
